The initial success of Sildenafil undeniably reshaped the medication landscape, but betting in companies heavily reliant on generic versions presents a uncertain picture. While early profits were significant, the expiration of patents and the emergence of cheaper alternatives have weakened the customer base. Consequently, a thorough assessment of p